// App-Quantinova.ai

: Medication for childhood interstitial lung diseases differs internationally

Researchers

Presenter

  • Sabine Witt

Principal Investigators

  • Boglarka Szentes

  • Andrew Bush

  • Steve Cunningham

  • Nural Kiper

  • Joanna Lange

  • Reiner Leidl

  • Suzanne Terheggen-Lagro

  • Nicolaus Schwerk

  • Deborah Snijders

  • Matthias Griese

  • Larissa Schwarzkopf

Medical Centers

  • Helmholtz Zentrum München – Institute of Health Economics and Health Care Management, Hanover, Germany

  • Imperial College, Royal Brompton Hospital, London, United Kingdom

  • Edinburgh University and Royal Hospital for Sick Children, Edinburgh, United Kingdom

  • Hacettepe Ihsan Dogramaci Children's Hospital, Ankara, Turkey

  • Department of Pediatrics and Endocrinology, Medical University of Warsaw, Warsaw, Poland

  • Academic Medical Hosptial Amsterdam, Amsterdam, Netherlands

  • Paediatric Pulmonology, Allergy and Neonatology, Hanover Medical School, Hanover, Germany

  • Department of Women and Children Health, University Hospital of Padova, Padova, Italy

  • Ludwigs-Maximilians-University, Dr. von Hauner Children's Hospital, Munich, Germany

Locations

  • Germany

  • United Kingdom

  • Turkey

  • Poland

  • Netherlands

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A